Chester County News and Community Website
PHILADELPHIA, PA — Century Therapeutics (NASDAQ: IPSC) will present new data on its experimental type 1 diabetes cell therapy at two scientific conferences this fall, a step that comes as …
Century Therapeutics Advances Diabetes Program With Conference Talks Read More
EXTON, PA — Red Rover will host a virtual forum in November focused on human resources, payroll and finance operations in K-12 school districts, creating what the company says is …
Red Rover Launches K-12 HR, Payroll Forum for School Leaders Read More
MALVERN, PA — Neuronetics Inc. (NASDAQ: STIM) will participate in an institutional investor conference next week, providing investors with an opportunity to hear the company’s perspective on the commercialization of …
Neuronetics Joins Investor Summit as Mental Health Market Evolves Read More
MALVERN, PA — Ocugen (NASDAQ: OCGN) will present updates on its modifier gene therapy platform and clinical data from its retinal disease programs at a series of investor and industry …
Ocugen to Present Gene Therapy Data at July Conferences Read More
MALVERN, PA — The Institutes CPCU Society will bring insurance and risk management professionals to Las Vegas in October for a conference focused on artificial intelligence, cyber threats, climate risk …
Insurance Conference Targets AI, Cyber Risks as Industry Shifts Read More
PHILADELPHIA, PA — Exyn Technologies (NASDAQ: EXYN, EXYNW) will present its autonomous navigation and mapping business to institutional and accredited investors next week as the company participates in the iAccess …
Exyn Targets Investors at Best Ideas Conference Read More
WILMINGTON, DE — Acorn Energy Inc. (Nasdaq: ACFN) will present to investors this week as the infrastructure monitoring company seeks to capitalize on growing recurring revenue and an expansion into …
Acorn Energy Highlights Recurring Revenue Growth Ahead of Investor Conference Read More
RADNOR, PA — Mineralys Therapeutics (Nasdaq: MLYS) will present new clinical data on its investigational hypertension treatment lorundrostat at ENDO 2026, as the company advances the drug through late-stage development …
Mineralys Data Presentation Highlights Heart Failure Biomarkers Ahead of FDA Review Read More
WILMINGTON, DE — Mirum Pharmaceuticals (Nasdaq: MIRM) and Incyte (Nasdaq: INCY) are set to present pivotal Phase 2 clinical data for investigational fibrodysplasia ossificans progressiva (FOP) treatment zilurgisertib this week, …
Mirum, Incyte Advance FOP Drug as FDA Review Continues Read More
BLUE BELL, PA — Unisys (NYSE: UIS) will meet with investors at two conferences this month as the technology services company continues outreach to institutional shareholders amid growing interest in …
Unisys Schedules Investor Conferences as Tech Firms Court Capital Read More